Literature DB >> 22717643

Methods for meta-analysis of individual participant data from Mendelian randomisation studies with binary outcomes.

Stephen Burgess1, Simon G Thompson2.   

Abstract

Mendelian randomisation is an epidemiological method for estimating causal associations from observational data by using genetic variants as instrumental variables. Typically the genetic variants explain only a small proportion of the variation in the risk factor of interest, and so large sample sizes are required, necessitating data from multiple sources. Meta-analysis based on individual patient data requires synthesis of studies which differ in many aspects. A proposed Bayesian framework is able to estimate a causal effect from each study, and combine these using a hierarchical model. The method is illustrated for data on C-reactive protein and coronary heart disease (CHD) from the C-reactive protein CHD Genetics Collaboration (CCGC). Studies from the CCGC differ in terms of the genetic variants measured, the study design (prospective or retrospective, population-based or case-control), whether C-reactive protein was measured, the time of C-reactive protein measurement (pre- or post-disease), and whether full or tabular data were shared. We show how these data can be combined in an efficient way to give a single estimate of causal association based on the totality of the data available. Compared to a two-stage analysis, the Bayesian method is able to incorporate data on 23% additional participants and 51% more events, leading to a 23-26% gain in efficiency.
© The Author(s) 2012.

Entities:  

Keywords:  Mendelian randomisation; causal inference; individual participant data; meta-analysis

Mesh:

Substances:

Year:  2012        PMID: 22717643     DOI: 10.1177/0962280212451882

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  6 in total

Review 1.  Meta-analysis methods for genome-wide association studies and beyond.

Authors:  Evangelos Evangelou; John P A Ioannidis
Journal:  Nat Rev Genet       Date:  2013-05-09       Impact factor: 53.242

2.  Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.

Authors:  Stephen Burgess; Robert A Scott; Nicholas J Timpson; George Davey Smith; Simon G Thompson
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

3.  Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19.

Authors:  Lucija Klaric; Jack S Gisby; Artemis Papadaki; Marisa D Muckian; Erin Macdonald-Dunlop; Jing Hua Zhao; Alex Tokolyi; Elodie Persyn; Erola Pairo-Castineira; Andrew P Morris; Anette Kalnapenkis; Anne Richmond; Arianna Landini; Åsa K Hedman; Bram Prins; Daniela Zanetti; Eleanor Wheeler; Charles Kooperberg; Chen Yao; John R Petrie; Jingyuan Fu; Lasse Folkersen; Mark Walker; Martin Magnusson; Niclas Eriksson; Niklas Mattsson-Carlgren; Paul R H J Timmers; Shih-Jen Hwang; Stefan Enroth; Stefan Gustafsson; Urmo Vosa; Yan Chen; Agneta Siegbahn; Alexander Reiner; Åsa Johansson; Barbara Thorand; Bruna Gigante; Caroline Hayward; Christian Herder; Christian Gieger; Claudia Langenberg; Daniel Levy; Daria V Zhernakova; J Gustav Smith; Harry Campbell; Johan Sundstrom; John Danesh; Karl Michaëlsson; Karsten Suhre; Lars Lind; Lars Wallentin; Leonid Padyukov; Mikael Landén; Nicholas J Wareham; Andreas Göteson; Oskar Hansson; Per Eriksson; Rona J Strawbridge; Themistocles L Assimes; Tonu Esko; Ulf Gyllensten; J Kenneth Baillie; Dirk S Paul; Peter K Joshi; Adam S Butterworth; Anders Mälarstig; Nicola Pirastu; James F Wilson; James E Peters
Journal:  medRxiv       Date:  2021-04-07

4.  Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators.

Authors:  Brandon L Pierce; Stephen Burgess
Journal:  Am J Epidemiol       Date:  2013-07-17       Impact factor: 4.897

5.  Sex Differences in the Risk of Coronary Heart Disease Associated With Type 2 Diabetes: A Mendelian Randomization Analysis.

Authors:  Tricia M Peters; Michael V Holmes; J Brent Richards; Tom Palmer; Vincenzo Forgetta; Cecilia M Lindgren; Folkert W Asselbergs; Christopher P Nelson; Nilesh J Samani; Mark I McCarthy; Anubha Mahajan; George Davey Smith; Mark Woodward; Linda M O'Keeffe; Sanne A E Peters
Journal:  Diabetes Care       Date:  2020-12-04       Impact factor: 17.152

Review 6.  A review of instrumental variable estimators for Mendelian randomization.

Authors:  Stephen Burgess; Dylan S Small; Simon G Thompson
Journal:  Stat Methods Med Res       Date:  2015-08-17       Impact factor: 3.021

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.